Article

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitors

2021-03-02

Abstract excerpt

<h4>Background</h4> Metastatic uveal melanoma (mUM) is a rare disease for which no systemic therapy has demonstrated overall survival (OS) benefit. There are no robust data on prognostic factors for OS in patients with mUM treated with immune checkpoint inhibitors (ICI). Retrospective and non-randomized prospective studies have reported response rates of 0-37% for anti-PD1/L1 +/-anti-CTLA4 ICI in mUM, indicating a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 544c978c-2b69-53c2-a5a2-2bfafcb08e99
DOI: 10.1101/2021.02.28.21252611

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitorsDOI 10.1101/2021.02.28.21252611Read

Uveal melanoma: From diagnosis to treatment and the science in between.Semantic proximity Read

Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?Semantic proximity Read

The Tongren-Ophthalmology Research Association of Clinical Evaluation - Uveal Melanoma (TRACE-UM): Objectives, Design, Current Results, and OutlookSemantic proximity Read

OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysisSemantic proximity Read

Prognostic Modeling of Patients with Metastatic Melanoma Based on Tumor Immune Microenvironment CharacteristicsSemantic proximity Read

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.Semantic proximity Read

Development of a 3-microRNA signature and nomogram for predicting the survival of patients with uveal melanomaSemantic proximity Read

Prognostic Impact of Autophagy and Immunity Related Biomarker for Uveal MelanomaSemantic proximity Read

Machine Learning-based Classifier to Decipher Immune Landscape of Uveal Melanoma and Predict Patient OutcomesSemantic proximity Read

Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year PeriodSemantic proximity Read

Machine Learning and Single-Cell RNA Sequencing Reveal Relationship Between Intratumor CD8 + T Cells and Uveal Melanoma MetastasisSemantic proximity Read

Update on Metastatic Uveal Melanoma: Progress and Challenges.Semantic proximity Read